THE METABOLIC SYNDROME IN OUTPATIENTS WITH PSYCHOSIS: A COMPARATIVE STUDY BETWEEN LONG ACTING INJECTABLE OLANZAPINE AND RISPERIDONE

CONTEXT: Literature shows that patients taking antipsychotic medication risk developing metabolic complications. OBJECTIVE: The study aims to compare the presence of the metabolic syndrome (MS) and its components in outpatients treated with long acting injectable (LAI) olanzapine and risperidone. DE...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Acta Endocrinol (Buchar)
Autors principals: Dehelean, L., Romosan, A.M., Manea, M.M., Papava, I., Andor, M., Romosan, R.S.
Format: Artigo
Idioma:Inglês
Publicat: Acta Endocrinologica Foundation 2019
Matèries:
Endocrine Care
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6992390/
https://ncbi.nlm.nih.gov/pubmed/32010353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4183/aeb.2019.342
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars